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The gene for murine Ia-associated invariant (1i) chains (1131
and 1i41) was characterized by sequence analysis. The gene
extends over - 9 kb and is organized in nine exons. Exon 1
encodes the 5' untranslated region and the cytoplasmic seg-
ment, exon 2 the membrane spaniing segment and adjacent
amino acids and exons 3-8 the extracytoplasmic portion of
1131. Putative promoter sequences were found upstream of
the start of the coding sequence. Between exons 6 and 7 an
additional, alternatively spliced exon 6b has been identified.
This exon is spliced into the mRNA coding for the li-related
Ii41 protein. Exon 6b encodes a cysteine-rich domain of 64
amino acids. It shows a remarkably high homology to the
repetitive elements in thyroglobulin, a precursor for thyroid
hormone. Based on this homology, it is suggested that this
domain (TgR) in Tg and in 1141 may play a role either in
hormone formation or as a carrier in the transport of
molecules (thyroid hormone or processed antigen respectively)
between intracellular compartments.
Key words: invariant chain gene/class II histocompatibility anti-
gens/alternative-splicing/thyroglobulin/antigen processing
portion on the extracytoplasmic side of the membrane (Lipp and
Dobberstein, 1986). The single cysteine residue on the
cytoplasmic side is fatty acylated (Koch and Hammerling, 1986).
Ii shares the membrane orientation and the site of fatty acylation
with the transferrin receptor (TR) which internalizes transferrin
and recycles it from an intracellular compartment to the plasma
membrane (Omary and Trowbridge, 1981; Schneider et al.,
1984). Because of its association and co-regulation with class
H MHC antigens, and its structural similarity to receptors, it has
been proposed that invariant chain may be involved in in-
tracellular transport or recycling of Ta and/or processed antigen
complexes (Kvist et al., 1982; Claesson and Peterson, 1983;
Cresswell, 1985; Koch and Hammerling, 1986; Miller and Ger-
main, 1986; Sekaly et al., 1986).
Immunochemical analysis has demonstrated that several forms
of murine Ii chain are associated with Ta antigens (Zecher et al.,
1984). Recently two mRNA species were described coding for
31-kd and 41-kd Ii-related proteins, Mi31 and 1i41 respectively
(Yamamoto, 1985b; Strubin et al., 1986b). 1i31 is expressed in
amounts 5-10 times higher than Ii41. After transfection of the
Ii gene into rat fibroblasts, both Ii31 and Ii41 were expressed
(Yamamoto et al., 1985b). Proteins with similar mol. wts (In33
A
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Introduction
Invariant chain (Ii) is a protein which is associated intracellular-
ly with the murine and human class II histocompatibility (MHC)
antigens, Ta and HLA-D respectively (Jones et al., 1978; Char-
ron et al., 1983; for review see Long, 1985). This assembly oc-
curs shortly after insertion into the membrane of the rough
endoplasmic reticulum (ER) (Kvist et al., 1982). After transport
to the Golgi complex and the addition of sialic acid residues, Ii
dissociates from the class MHC antigens (Machamer and
Cresswell, 1982; Rudd et al., 1985). Class II MHC antigens are
transported to the cell surface where they are involved in the
presentation of foreign antigens to T-cells (Unanue, 1984). The
fate and function of Ii is unclear.
The expression of Ta antigens and Ii is coregulated even though
the respective genes are located on different chromosomes
(Claesson-Welsh et al., 1984; Koch and Harris, 1984; Yamamoto
et al., 1985a; Momburg et al., 1986). Interferon-y (IFN-'y) and
B-cell stimulating factor (BSF-1) induce expression of both Ia
antigens and Ii (Collins et al., 1984; Koch et al., 1984; Polla
et al., 1986). Proteins homologous to Ii are found in all species
which are known to express class H MHC antigens (Sung et al.,
1982; Quill and Schwartz, 1983).
Murine Ti chain is a 31-kd type II membrane glycoprotein which
spans the membrane once and exposes the 29 amino-terminal
residues on the cytoplasmic and the glycosylated carboxy-terminal
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Fig. 1. Physical map of the mouse Ii gene. (A) The 40-kb insert in cos
10.7 containing the mouse Ii gene was partially digested with six restriction
enzymes and a restriction map constructed. The Ii gene was located by
using mouse or human cDNA probes on two adjacent EcoRI fragments of
2.9 and 10 kb in length. They are indicated by slanted lines. (B) Sequencing
strategy for the Ii gene. Fragments as indicated in the figure were subcloned
into plasmid vectors, deletions were introduced by DNase I treatment and
selected plasmids sequenced. The 5' end of the gene is to the left and the 3'
to the right.
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-249 CCTGATGAATCCAGAAGTCTGCCTAGAAACAAGTGATGATAGCCCTGGCCAGCCAATGGGATCATGCAGGCCTTTCTACCTGTTTAGGGAACTCCC *CTTCATCCTGCCCAGGGAGGCAGCTTTG
(15 mer)
-124 AGTGAGTGGGGAATTTCCAGATTTGTGGC TTTCAGTTCCACATCTACCATGTGGGCGGAGTGACCTGCTGTGGGCGAATCAGATTCCTTCCAGTATCAGCTTTAGAGGTGATCTTGGGGCTCAA
(CAAT-BOX) (Spl binding-site) (TATA-BOX)
Exon 1
2 GGGTC_CCAGACACACAGCAGCAGCAGCAGCAGCAGCAGCAGCAACAGCAGCAGCAGCAGCAGCGCCTGTGGGAAAAACTAGAGGCTAGAGCCATGGATGACCAACGCGACCTCATCTCTAACCAT
(OPA-sequence) MetAspAspGlnArgAspLeuIleSerAsnHis
127 GAACAGTTGCCCATACTGGGCAgACCGCCCTAGAGAGCCAGAAAGgtatgtgtgaataccagcagagagcccttacctctggaggacacagaatgcaggcctggggagggacacagagctctgttg
GluGlnLeuProIleLeuGlyAsnArgProArgGluProGluAr
251 caggaaggttgccttgagtgaccttgagcgctgattttctgagtgaatTTTATTTATTTATTTATTTATTTATTTATTTATTTAT -- 3.5 kb
--
Exon 2
1 tccgtc ccaacagGTGCAGCCGTGGAGCTCTGTACACCGGTGTCTCTGTCCTGGTGGCTCTGCTCTTGGCTGGGCAGGCCACCACTGCTTACTTCCTGTACCAGCAACAGGGCCGCCTAGACALAG
gCys SerArgGlyAlaLeuTyrThrGlyVa lSerValLeuValAlaLeuLeuLeuAl aGl1yGlnAl aThrThrAlaTyrPheLeuTyrGlnGlnGlnGlyArgLeuAspLy s
0
12 6 CTGACCATCACCTCCCAGAACCTGCAACTGGAGAGCCTTCGCATGAAGCTTCCGAAATgtgcgtgc tccacc tgtccc tcac ctcacagac atca t ttctccat t tagcccc tcccga tctgcc t
LeuThrIleThrSerGlnAspLeuGlnLeuGluSerLeuArgMetLysLeuProLysS
Exon 3
251 tcctcccccgcaccggtttcaaatcttaacccctgggttccttactgccttggacctggactcatactgtcctgc ctgccccacagCTGCCAAACCTGTGAGCCAGATGCGGATGGCTACTCCCT
erAlaLysProValSerGlnMetArgMetAlaThrProL
376 TGCTGATGCGTCCAATGTCCATGGATAACATGCTCCTTGGGgtaaggaagg -- 200 bp --
euLeuMetArgProMetSerMetAspAsnMetLeuLeuGly
1 cttcctccaagtctttggctgcaaaaatgctgttactcataagattactattggtaccttatccagggcagagcacatc aatcgaacggtgccaaatggtcagtcc tgaaaacatacataagt ta
12 6 gcatgatacagacggggcaggt ttaattaggactagtggtgt atatatatatagac atataatatatgcaagcaatgacaatgaatgaaaaaagaggcc atgaatttgaagtgaagcaggaagga
2 51 aca tatgggagggc ttgggaggaggaagc aaac tctgctattgggaaggc tctgacaagc ttctgcccgcctgaccagagagggcatagaggcaggaagggcgtgaggggc tggc ac ttccatgt
Exon 4
376 taggaggtggcagatttgagctgttgagtgcaagcacctgactcgtactagactatagctgctgatccctgcaatgctggtaaccctgttcccttccccacagCCTGTGAAGAACGTTACCAAGT
ProValLysAsnValThrLysT
501 ACGGCAACATGACCCAGGACCATGTGATGCATCTGCTCACGgtgagtatcagagc g agctctgggtcacgtgggacccggccctcactcatgggttaggctcactataaactcaaca
yrGlyAsnMetThrGlnAspHisValMetHisLeuLeuThr
6 26 catgc ttagtccaaggaatacaaggtggt ccttaactgttgcgtacagtccatcccctacccaccttgagataagagtctatgtagtcctggaaccgactatgtagaacagttggctttgaactt
7 51 acaatttcggctttgaactc acaatttgcctgcc tctcgtcccagtgctagga ttaaaggcgtgcatcac taggccaggttccagccacctcact tttgaggagt taaaaa ttatggtcca ttga
876 gactggaaatataactcaaagattaaaaacaccacctactcttccaCaaatcctqaattcaattcccaaccacctcataactcacaaccatctgtaatataaatccaatqtcctcttctagta(Alu-sequence)
1001 tt__agacaaacat tcqcatacataAAATAAATAAATAAATc_ttttaaaaaaatcaaattaaggtccaatggattgacttggccacaataccatgttctccttcccaaattaatatt
112 6 gcacatgcttgcttcgtgtcagcacagtgcatggcaatggc tc ttggcctacagcagggaacac tggttgtgtgaggacaggcagaggacccagacagagggaaaaaac tggaqggtgc tggttc a
12 51 ctcctgacscctgactggagttccatagctgggtgcsccctcaccgctgctctccaacatggggaccaggggccaggcttggtgtggc taatgtccattcctcagaacgaaggcctgggaacatggg
Exon 5
1376 gtgcacatctccccttatttattccgggggttctctataacttccccttgccctgccgctctgcagAGGTCTGGACCCCTGGAGTACCCGCAGCTGkAGGGGACCTTCCCAGAGAATCTGkAGC
ArgSerGlyProLeuGluTyrProGlnLeuLysGlyThrPheProGluAsnLeuLysH
1501 ATCTTAAGAACTCCATGGATGGCGTGAACTGGAAGgtaaacagcccctgttggaatctcttcttcttcccacagtagcttcaggactagaaagaggcaaagggaggactagggctgctgttctctisLeuLysAsnSerMetAspGlyValAsnTrpLys
1626 tgaagctactgagggccttctaacattcacgacacccctgtggtctttaagaggcactgaggctgaagctggaccctccaagtttgtagtcaaggcagagtccagaagggtaggcggttgactc
Exon 6
1751 ctgaccctgaccatccatccacctctgatctccgttagATCTTCGAGAGCTGGATGAAGCAGTGGCTCTTGTTTGAGATGAGCAAGAACTCCCTGGAGGAGAAGAAGCCCACCGAGGCTCCACCT
IlePheGluSerTrpMetLysGlnTrpLeuLeuPheGluMetSerLysAsnSerLeuGluGluLysLysProThrGluAlaProPro
18 76 AAAGgtaccaggacgggagct tcggcctgccacagtgacc tactctctcagctcagtcttttc tcgcctgttgttccttcaggttcggaaacccttatatcctatccgtgggtctgt tct ttcac
LysG ==> Exon 7
V ==> Exon 6b
2001 ac acatgtccagagtacagaggcctctaggtc tc tgtcttggagcaaaaccaac tgaaaaggtacccggcagagtcsccccagcagtagataaagatacaaggaggagacggaatc atgattgt c
212 6 cagatagagc cctgggacc tctcac ttcacggc aggccagcatacaggaggctgaggcataaagcattggggaacgcc tctgc tttaccttggtgc tgcc tc taac ttgc tgtgagtgc tggacg
22 51 agcccatcccactggcttctgtgtcccacaagtggaaggctagaggcccatactgctctggacctaagtitctctgatatataaatcsccttacatgctatctcaaccagcttctagtaatgtttg
2 37 6 aatcccctc tccagcgtccccaacaagtggcagcccccatttctactttatcccagtaaaggaaggtcagattcccagaggtgtccccat tactgtccccc tgaaacagaataatgtaacaaatg
2 501 cagaataattat tactggggcaaatgacacctataagtcatgctttctct t tttggatc ttac tggt ttcagac tcaggcctcagttttctcatctaggc tatgggtc taccccataaggaaagc
Exon 6 b
2 6 26 aatttggataggcattaagcc atggagtgGTGTGTGTGTGTGTGTgggtc tc tgctc tgctgagatcctggcccagagtccacccac tcactgtc ttcatcatgeccttcagTACTGACCAAGTGC
alLeuThrLysCys
2751 CAGGAAGAAGTCAGCCACATCCCTGCCGTCTACCCGGGTGCGTTCCGTCCCAAGTGCGACGAGAACGGTAkCTATTTGCCACTCCkGTGCCACGGGAGGCACTGCTkCTGCTGGTGTGTGTTCCC
GlnGluGluVa lSerHis IleProAlaVa lTyrProGlyAl aPheArgProLysCysAspGluAsnGlyAsnTyrLeuProLeuGlnCysHi sGlyArgHisCysTyrCysTrpCysValPhePr
2 876 CAACGGCACTGAGGTTCCTCACACCAkGAGCCGCGGGCGCCATAACTGCAGTGgt aagcaggggacaccgtgtcac ataatc taaaggac taggaagctc taggaaggc caagggt ccaaaggt c
oAsnGlvThrGluValProHisThrLysSerArgGlyArgHisAsnCySerG
3001 cc tcccagtatacatggggtcaggacatgggttggc tgtgcctgggagcatccaccatcagtcacacacacaccagcsccct ttctccacacaggaac tcc ttgtgtcc t tctaatc t ttgtc tc t
3126 tcttctccgcacgctgtcctgcactggagtcccacagacccacccgtctcactgtatccccaaccacactgtatgctctggtgcctcctttgccaagt tcaaggcacagtggcaacaGTGTGTGT
Exon 7
3 251 GTGTGTGTGTGTtggggtaagaataacagtgagecctga tgc ttcc cttgcagAGCCACTGGACATGGAAGACCTATCTTCTGGCCTGGGAGTGACCAGGCAGGAACTGGGTCAAGgtaagggggg
luProLeuAspMetGluAspLeuSerSerGlyLeuGlyValThrArgGlnGluLeuGlyGlnV
3 37 6 gatcacagagagggccacccacatgcagactctggtgacactgggacattcatcactatcactgggatggttt ttccagaatggatggtggctgggagcacagtactacc tgagc ttagcagggg
Exon 8
3 501 gacagactga tctgcagtt ccaagatgttgggcagaggaggc agggacaacaaac tggtggc ccagctgtatcaacctgtgcttctc t tcccagTCACCCTGTGAAGACAGAGGCCAGCTCTGCA
alThrLeu
3 6 26 CAGCAGCAGCGCCCCCTGCTCTCCTGTGCCTCAGCCCTTCTTATGTTCCCTGATGTCACACCCCACTTCCCGTCTCCCTGCACCCTGGGGCTTGAGACTGGTGTCTGTTTCATCGTCCCAGGACA
3751 CGGCAAATGAAGTCAGAACAGAAGGAGGACGCTGGAGGGCCTTGCTGGCTACCGCTATCTAAAGGGAACCCCCATTTCTGACCCATTAGTAGTCTTGAATGTGGGGCTCTGAGATAAAGGC CCGC
3 8 76 AGACAGGGACAAGGGATGCCCTAC CCTTAACCTAGGCTGGACACATTTGCTGCCTTCTCCTCAAGGAAGAAGAAC CCAAGCCCCTCCTCCCAGTAACCCCTCCTCACATCCTGCCACCCCCCCTC
4 001 AAGCCCCACCCCCTTTCAGGTTCCTTGCTCAGCCAAGCTTGTCAGCAGCCTGTAGGATCATGGTTCAAGTGACAATAAAGGAAGAAAGTAGAa cact cttgc tt c tgcct c tt 4113
( Poly-adenylation signal )
Fig. 2 Sequence of the mouse li gene. The nucleotide sequence is shown together with the predicted amino acid sequence of nine exons. Exon 6b is an
alternatively spliced exon used to generate the Ii41 protem. Potential regulatory sequences, the CAAT box, one consensus SpI protein binding site(GGGCGG), and the TATA box are indicated at the 5' end of the gene. A 15-mer segment at -220 is indicated which is highly homologous to a 15-mer
segment found in mouse and human class II MHC antigen genes. Downstream of the putative transcription start site, an alternating CAG structure OPA-
sequence is found. Alternating TTTA, AAAT and GT nucleotides are indicated by capital letters. An Alu-type repeat element in the fourth intron and the
polyadenylation signal AATAAA in the 3' non-coding region are underlined. In exon 6b the sequence highly homologous to the repetitive element in
thyroglobulin (TgR) is also underlined. Potential glycosylation sites in the deduced amino acid sequence are indicated by an * and the cysteine residue to
which palmitic acid is bound (exon 2) by a dot.
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Fig. 3. Outline of the exon-intron structure of the murine Ii gene. Eight exons encode Ii31. Closed boxes indicate exons for coding sequences, open boxes
for non-coding sequences. One exon encodes the cytoplasmic and one the membrane-spanning segment. Six exons encode the extracytoplasmic part. An
additional exon, 6b, is used in mRNA coding for 1141. This exon encodes a domain highly homologous to a repetitive domain in thyroglobulin (TgR). The
site for fatty acid acylation is indicated by a dot, sites for potential N-glycosylation by x. C: cytoplasmic, M: membrane-spanning; EC: extracytoplasmic
segment.
and In41) were also found in human lymphoblastoid cell lines
(Quaranta et al., 1984; Strubin et al., 1986b). Strubin et al. con-
cluded from sequence analysis of In41 cDNA that the 41-kd pro-
tein results from differential splicing of an invariant chain gene
transcript (Strubin et al., 1986b). Other forms of invariant chain
(In35 and In43) were found in human cells. These were shown
to be translated from an AUG initiation codon upstream of that
used for the production of the 33-kd and 41-kd major forms of
human invariant chain (Strubin et al., 1986a).
The structure of the human invariant chain gene has recently
been determined (Kudo et al., 1985; O'Sullivan et al., 1986).
It was shown to be organized in nine exons. One exon codes
for the 5' untranslated region and the cytoplasmic segment, one
for the membrane spanning segment and seven for the extra-
cytoplasmic portion.
We describe here the nucleotide sequence of the murine Ii gene.
Several consensus sequences with possible regulatory functions
are found in the 5' untranslated region. Comparison with the
analogous sequence of the human gene reveals a strong homology
in all exons including the exon 6b which by alternative splicing
gives rise to the 41-kd 1i41 protein.
Results
Structure of the Ii gene
The isolation and expression of a genomic clone coding for Ii
chains has recently been described (Yamamoto et al., 1985b).
The 40-kb genomic clone cos 10.7 was shown to contain the com-
plete gene coding for 1i31 and Ii41. We mapped the genomic
clone cos 10.7 by restriction analysis. A restriction map of the
Ii gene and its flanking regions is shown in Figure IA. Hybridiza-
tions with 5' and 3' invariant chain cDNA probes revealed that
the entire Ii gene is contained on two EcoRI fragments, a 2.9-kb
fragment with the 5' end and a 10-kb EcoRI fragment with the
3' end of the gene.EcoRI or Hindm fragments as shown in Figure
lB were subcloned and all the exons and several of the introns
were sequenced. The sequences are shown in Figure 2. Com-
parison of the Ii31 cDNA sequence with the genomic sequence
revealed that the Ii gene is composed of eight exons (Figure 3).
Exon 1 encodes the 5' untranslated region and the amino-terminal
portion of the cytoplasmic segment. Exon 2 encodes the three
amino acids located on the cytoplasmic side, the membrane-
Table I. Per cent homology between murine and human invariant chain exons
and introns
% homology Number of exon
5'NC 1 2 3 4 5 6 6b 7 83'NC
Exon 84 76 84 72 81 77 80 88 83 75 53
Intron 56 50 50 52 56 55
spanning segment and 23 amino acid residues on the extracyto-
plasmic side of the membrane. Six exons (3-8) encode the extra-
cytoplasmic portion. The two sites for the addition of N-linked
carbohydrate side chains are encoded by exon 4. Comparison
of the murine Ii gene sequence with the human one revealed the
same exon- intron structure. The homology between the exons
was found to be 72-84% and between the introns -50% (Table
I).
Potential regulatory sequences in the 5' and 3' non-coding regions
Of the 5' flanking region, 342 bp were sequenced (Figure 2).
The sequences CATCT and TTTAA were found upstream of the
ATG initiation codon (underlined in Figure 2). They show strong
homology to the 'CAAT' and 'TATA' consensus sequences
which are indispensable for specific initiation of transcription
(Breathnach and Chambon, 1981). A consensus SpI protein bin-
ding site (GGGCGG) was found upstream of the TATA box
(Gidoni et al., 1984). The cap site of Ii gene transcription has
not yet been determined. In the human Ii gene the start of
transcription has been determined to be located 22 bp downstream
of the proposed TATA box (Strubin et al., 1984a). The analogous
position in the murine gene is arbitrarily assigned + 1. The se-
quence between the TATA box and the ATG initiation codon
shows a repetitive CAG sequence characteristic for so-called OPA
elements previously found in homoeotic and other genes (Whar-
ton et al., 1985). Its functional relevance remains to be shown.
As the expression of Ii gene is induced by IFN--y we com-
pared its 5' sequence with those of other IFN--y inducible genes
such as the class H histocompatibilty antigens. Two elements,
a 15-mer and a 8-mer, were previously suggested to be involved
in the transcriptional regulation by IFN--y (O'Sullivan et al.,
1986). Only the 15-mer sequence could be identified in the Ii
gene (-228 to -213) (Figure 2). Control of Ii gene expression
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Fig. 4. Alignment of the homologous regions between Ii41 and thyroglobulin. The segment in Ii41 encoded by exon 6b and the 10 times repeated homologous
regions in thyroglobulin (TgR) are indicated by boxes with slanted lines. Segments with the highest homology are connected by lines. Potential N-
glycosylation sites are indicated by x. C: indicates the cytoplasmic segment; M, membrane-spanning segment; EC, extracytoplasmic segment; S, signal
sequence; TgACE, the segment homologous to acetylcholinesterase (Swillens et al., 1986); f, hormonogenic tyrosines.
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Fig. 5. Alignment of part of the amino acid sequence encoded by exon 6b of mouse (m) and human (h) invariant chain gene with the second repetitive units
of human thyroglobulin (TgR) and a consensus TgR sequence. The consensus sequence (CS) has been established from a comparison of five of the human Tg
repetitive units (Malthiery and Lissitzky, 1985). Dots indicate a gap, dashes indicate variable amino acid residues.
is also coupled to non-proliferation. The Ii gene and the metal-
lothionine gene are inducible by the arrest of proliferation
(Rahmsdorf et al., 1983; Angel et al., 1986). Between the TATA
and the ATG start site for translation a region of homology was
found.
Exon 6b encodes a cysteine-rich domain homologous to part of
thyroglobulin
After transfer of the murine Ei gene into rat fibroblasts, two related
invariant chain proteins were identified, one of 31 kd, i3 1, and
one of 41 kd, Ii41 (Yamamoto et al., 1985b). It has been sug-
gested that the mRNAs coding for these two proteins are pro-
duced by differential splicing. In order to search for the sequence
in the Ii gene that encodes Ii41 protein we used its known bio-
chemical properties and the homology to the recently sequenced
cDNA for the human 41-kd form of the invariant chain, In41
(Strubin et al., 1986b). 1i41 should contain at least three sites
for N-linked glycosylation. Mi31 and Ii41 should have common
amino- and carboxy-terminal portions; and the additional seg-
ment in Ii41 should have a mol. wt of -5 kd and be rich in
cysteins (Yamamoto et al., 1985b; Lipp and Dobberstein, 1986).
Based on this information, a sequence between the sixth and
seventh exons was found which fulfilled all the criteria for an
additional exon used in the mRNA coding for the 41-kd protein.
This exon 6b contains 192 bp between consensus splice sites.
The resulting reading frame and the deduced amino acid sequence
is shown in Figure 2. Exon 6b encodes 64 amino acid residues
of which seven are cysteines. It has two potential sites for the
addition of N-linked carbohydrate side-chains. The exon 6b shows
88% homology to the human p41-1 cDNA (Table I and Strubin
et al., 1986b).
The deduced protein sequence from exon 6b was compared
to the sequences in the protein data base maintain by the Na-
tional Biomedical Research Foundation, Washington, DC by us-
ing the search program FASTP (Lipman and Pearson, 1985).
A significant homology of 38% was found by Patrick Argos
(EMBL) to the repetitive sequence close to the amino terminus
of thyroglobulin (Tg). This sequence centres around the tetrapep-
tide Cys-Trp-Cys-Val and is 10 times repeated in Tg (Figure 4)
(Malthiery and Lissitzky, 1985; Mercken et al., 1985a,b). A con-
sensus sequence for the Tg repetitive elements (TgR) has been
derived showing conserved positions for Cys, Pro and Gly
residues (Malthiery and Lissitzky, 1985). When the amino acid
sequence deduced from exon 6b was compared with this con-
sensus sequence, nearly all positions were found to be conserv-
ed (Figure 5). Mouse and human 6b sequences were identical
in all positions to the TgR consensus sequence (Figure 5). It is
interesting to note that the deduced cysteine at position 39 of the
mouse 6b exon is not conserved in the human 6b exon and is
also not part of the TgR consensus sequence. In contrast, all the
other cysteine residues are conserved between the TgR and the
6b segment.
Discussion
The sequence and exon- intron structure of the murine Ii chain
gene were determined. When compared to the human invariant
chain gene, a high similarity in the overall structural organiza-
tion, and particularly between the exons, was found. However,
one significant difference was observed in the 5' untranslated
regions. The human In33 and In35 proteins result from alter-
native initiation at two in-phase AUG codons (Strubin et al.,
1986a). Only the second initiation site was found in the 5' un-
translated region of the mouse Ii mRNA (Figure 2). It thus ap-
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pears that the 35-kd form in man might not have an essential
function distinct from the 33-kd one.
The 41-kd form of invariant chain, in contrast, is found in all
species which have been screened for its presence. This form
is the result of alternative splicing (Yamamoto et al., 1985b;
Strubin et al., 1986b). The exon used in this event is located
between exons 6 and 7 and is therefore named 6b. Interestingly,
when exons of the human and murine invariant chain gene were
compared, exons 6b showed the highest homology, 88%
homology was found between exons 6b, whereas 72-84% bet-
ween the others (Table I).
The mechanism of alternative splicing is not yet understood.
Examination of introns between the sixth and seventh exons did
not reveal any obvious sequence motifs which might effect effi-
ciency of splicing. Several other genes have been found to employ
alternative splicing. These include the T36 gene in human T cells
(Tunnacliffe et al., 1986) and the H-2 class I genes (Kress et
al., 1983; Transy et al., 1984). In the T36 gene a stretch of44 bp
of alternating GT was found to flank the alternatively spliced exon
(Tunnacliffe et al., 1986). Stretches of alternating GT are also
found in the Ii gene between exons 6 and 7. Their significance
for alternative splicing remains to be shown.
Exon -intron organization of the Ii gene is very similar to that
found for the asialoglycoprotein receptor (ASGR) gene (Leung
et al., 1985). ASGR, like the Ii31 and 1i41 proteins, is a type
II membrane protein. The cytoplasmic and membrane spanning
segment ofASGR are each encoded by separate exons. Five ex-
ons encode the extracytoplasmic segment. The carbohydrate bin-
ding site in ASGR has been localized in the carboxy-terminal
segment encoded by exons 7-9. The functional domain in Ii
chains has not yet been identified.
Comparison of the biochemical properties of the Ii31 and 1i41
chain had revealed an extensive similarity. An additional cysteine-
rich domain has been postulated for the 1141 chain (Lipp and Dob-
berstein, 1986). Exon 6b codes for 64 amino acid residues, seven
of which are cysteines. This segment in the Ii41 protein is located
close to the carboxy terminus on the extracytoplasmic side of
the membrane (Figure 3). Cysteine residues in secretory and
membrane proteins are often found to organize structurally and
functionally distinct domains. Best examples are protein domains
of the class I and II histocompatibility antigens (Nathenson et
al., 1981) immunoglobulins (Sakano et al., 1979) and the low
density lipoprotein (LDL) receptor (Yamamoto et al., 1984). A
structural motif of repeated, cysteine-rich sequences was, for in-
stance, demonstrated for the human EGF and LDL receptors (Rail
et al., 1985). When a protein data base was searched for se-
quences homologous to the segment encoded by exon 6b, a strik-
ing homology of 38% was found to a cysteine-rich segment in
thyroglobulin (Tg). This segment is 10 times repeated in the
amino-terminal half of Tg (Figure 4). A consensus sequence for
the cysteine-rich TgR has been proposed. It centres around the
sequence motif Cys-Trp-Cys-Val (Malthiery and Lissitzky,
1985). The entire TgR consensus sequence is found conserved
in the sequence of mouse and human exon 6b (Figure 5).
What could be the structural and functional significance of such
an extensive homology? Tg is an iodinated precursor protein for
the production of thyroid hormone (Wollman, 1969). Bovine Tg
is a glycosylated phosphorylated and sulfated protein of 2750
amino acid residues (for review see Herzog, 1984). It is a dimeric
glycoprotein of 660 kd which is secreted by the thyrocytes and
stored in the lumen of the thyroid follicle. Here the protein
becomes iodinated at tyrosyl residues and at 3-4 of these residues
thyroxine (T4) and triiodothyronine (T3) are formed. These are
located at the extreme ends ofTg on amino acid residues 5, 2555,
2569 and 2748 (Figure 4 and Mercken et al., 1985b). Active
hormone is released after endocytosis or phagocytosis of thyro-
globulin and its hydrolysis most likely in lysosomes. Some Tg,
however, seems to escape lysosomal degradation and thus ap-
pears intact in the serum (Van Herle et al., 1979; Herzog, 1984).
It has been suggested that the large thyroglobulin structure has
evolved for efficient and regulated iodination and coupling of
the hormonogenic tyrosines.
The exon 6b of the Ii gene codes for 64 amino acid residues.
Its amino acid sequence between residues 20 and 64 is as homo-
logous to the second TgR as the 10 Tg repeats are among each
other (Figures 4 and 5). It has been proposed that the TGRs have
arisen by gene duplication of a primordial gene coding for a
60 amino acid long building block (Musti et al., 1986). This sug-
gestion is further supported by the location of exon-intron boun-
daries within the Tg gene. Most of the TgR units are encoded
by separate exons (Musti et al., 1986; R.Di Lauro, personal com-
munication). Therefore, the exon 6b of the Ii gene might be deriv-
ed from the same primordial building block as the 10 TgR units
in the Tg gene. As the homology is high between the TgR
segments in Ii41 and in Tg, these two segments might perform
similar functions.
The function of the 10 TgR elements in Tg is not known. It
has been suggested that the unusually large Tg protein structure
supports the efficiency of iodination and the formation of the hor-
monogenic tyrosines. It is conceivable that TgR segments func-
tion in the formation of iodinated hormones. Hormone formation
on the TgR molecule occurs outside the cell in the thyroid folli-
cle. If Ii41 was a hormone precursor similar to Tg, one should
find it on the cell surface. No clear evidence for a cell surface
location has, however, been found for Ii41 protein. Clearly, more
detailed studies are required to elucidate a possible hormone func-
tion of Ii41.
Tg undergoes extensive intracellular transport. It is a typical
secretory protein which is secreted into the thyroid follicle,
iodinated, endocytosed, degraded in the lysosomes and the hor-
mone finally released in the circulation (Herzog, 1984; Vassart
et al., 1985). There must be some structural elements in Tg that
direct this molecule to the different stations. The TgR-element
could function in the transport to the lysosomes or in the transport
of T4 and T3 out of the lysosomes to the basal cell surface. A
function involving a lysosomal or acidic compartment has also
been suggested for invariant chains. This was largely based on
the transient association of Ii3 1 and Ii41 with class II MHC an-
tigens and their dissociation in an acid compartment (Machamer
and Cresswell, 1984; Nowell and Quaranta, 1985). Class II MHC
antigens are involved in the presentation of foreign antigens to
T cells. Most antigens have to be processed before they can ef-
ficiently be presented. Processing appears to occur in an intra-
cellular acidic compartment and involves in most cases proteolytic
degradation (for review see Unanue, 1984). The two best-
characterized acidic compartments in the cell are the endosomes
and the lysosomes.
Digestive enzymes are well characterized in lysosomes. It has
always been an enigma how processed antigen is retrieved from
the processing compartments, associates with class II antigens
and appears in association with class II antigens on the cell sur-
face. Could 1i31 and Ii41 perform functions in the retrieval of
antigen from different processing compartments? Each of these
molecules might then serve a different route, one an endosome-
like coiPla)rtment (li31) and one the digestive lysosome compart-
ment (1i41).
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It is not yet known in which form thyroid hormone reaches
the cell surface and enters the circulation. Three to four hor-
monogenic peptides are released from one molecule of thyro-
globulin. It is conceivable that the 10 TgRs are involved in the
transport of hormone or hormonogenic peptides from the
lysosomes to the cell surface where the hormone is released into
the circulation. If this assumption is correct, then the TgR
elements in Ii41 would be a carrier for processed antigen and
in Tg for hormonogenic peptides or hormone between the lyso-
somes and an endosome-like compartment or the cell surface.
Materials and methods
Cosmid and plasmids
The genomic Ii chain clone cos 10.7 containing the entire gene for Ii chain was
selected from a cosmid library made from AKR mouse DNA. It was obtained
from M.Steinmetz, Basel (Yamamoto et al., 1985b). Plasmid pli-5 containing
most of the coding sequence of Ii chain and the 3' non-coding region has been
described previously (Singer et al., 1984). It lacks the sequences coding for the
cytoplasmic segment of Ii and part of the membrane-spanning region (Singer et
al., 1984). Plasmid p-y2 was obtained from P.A.Peterson, Sweden. It encodes
the entire human invariant chain (Claesson et al., 1983). Plasmid, Ii-5 was used
to locate the 3' end of the 1i gene and the 5' 320-bp PstI fragment was used to
identify its 5' end.
DNA mapping, subeloning and sequencing
A restriction map of the 40-kb insert in clone cos 10.7 was established by using
the methods of Rackwitz et al. (1985) and Zehetner and Lehrach (1986). By
Southern blotting, using murine and human cDNAs as probes, two adjacent EcoRI
fragments of 2.9 and 10 kb were identified to contain the Ii gene (Southern, 1975)(Figure 1). The 2.9-kb EcoRI fragment was further deletion subcloned by the
method of Frischauf et al. (1980). Size-selected subclones were sequenced either
by the Sanger dideoxy-chain termination method (Sanger et al., 1977) or by the
method of Labeit using a-phosphorothioates (Labeit et al., 1986). In the latter
method the a-thiotriphosphate analogs of deoxynucleoside triphosphates are us-
ed to incorporate exonuclease IE-resistant residues into DNA (Labeit et al., 1987).
The 10-kb EcoRI fragment was digested with HindH and the resulting fragments
subcloned into pUC8 or pBr322 (see Figure 1 for details).
The 3' end of the 2.3-kb EcoRI-HindmI fragment was sequenced after clon-
ing into pBR 322. The 0.75-, 3.7- and 0.8-kb fragments were cloned into pUC8
and their 5' and 3' ends sequenced. The 3.7-kb fragment was deletion subcloned
(Frischauf et al., 1980) and selected fragments with deletions in their 5' end,
sequenced. The localization of the fragments is shown in Figure lB.
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